SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (8612)2/2/2001 8:01:15 PM
From: hm  Respond to of 9719
 
Interesting article. However, the bit quoted below is at best misleading & makes some of the reform-the-FDA rhetoric ring hollow:

"But safety is resolved in the first of three required phases for drug approval, and it is relatively inexpensive to prove. Most of that $0.5 billion is spent proving "efficacy," that a drug will perform as claimed, using massive, placebo-controlled clinical trials."

If only safety could be "proven" in Phase I....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News